McKesson Corporation

MCK

US58155Q1031

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-03-05 pm EST			5-day change	1st Jan Change
931.35 ^USD	-4.84%		-4.42%	+13.54%

Mar. 05	Mckesson Corporation Announces CFO Transition	CI
Mar. 05	McKesson Corporation Announces Executive Changes	CI

Sector Update: Health Care

Published on 02/05/2026 at 03:24 pm EST

MT Newswires

Latest news about McKesson Corporation

Mar. 05	Mckesson Corporation Announces CFO Transition	CI
Mar. 05	McKesson Corporation Announces Executive Changes	CI
Mar. 05	McKesson names Sysco's Cheung CFO as Vitalone retires	RE
Mar. 05	McKesson CFO Britt Vitalone to Retire; Kenny Cheung Named Successor	MT
Mar. 05	McKesson CFO Vitalone to retire	RE
Mar. 05	McKesson announces planned CFO transition	RE
Mar. 04	McKesson Insider Sold Shares Worth $2,697,750, According to a Recent SEC Filing	MT
Mar. 02	Leerink Partners Adjusts Price Target on McKesson to $1,085 From $975, Maintains Outperform Rating	MT
Feb. 23	McKesson Insider Sold Shares Worth $328,013, According to a Recent SEC Filing	MT
Feb. 23	Bubly? Sparkling Water Launches Limited-Edition Galactic-Inspired Flavors	CI
Feb. 20	Doseology Sciences Inc. Appoints Larry Latowsky as Executive Chairman of the Board of Directors, Effective February 18, 2026	CI
Feb. 18	Barclays Adjusts Price Target on McKesson to $1,050 From $960, Maintains Overweight Rating	MT
Feb. 13	McKesson Insider Sold Shares Worth $282,817, According to a Recent SEC Filing	MT
Feb. 10	JPMorgan Adjusts Price Target on McKesson to $1,107 From $983, Maintains Overweight Rating	MT
Feb. 09	Firebrick Pharma Limited Appoints Al Moghaddam as Non-Executive Director, Effective March 1, 2026	CI

McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.

Employees

44,000

Sector

Pharmaceuticals

More about the company